ZB11ALD-S16-5
EHTJUi005-A-1
General
Cell Line |
|
hPSCreg name | EHTJUi005-A-1 |
Cite as: | EHTJUi005-A-1 (RRID:CVCL_B0JM) |
Alternative name(s) |
ZB11ALD-S16-5
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | |
Last update | 30th August 2021 |
User feedback | |
Provider |
|
Generator | East Hospital Affiliated to Tongji University (EHTJU) |
Owner | East Hospital Affiliated to Tongji University (EHTJU) |
Distributors | |
Derivation country | China |
External Databases |
|
BioSamples | SAMEA8904410 |
Cellosaurus | CVCL_B0JM |
Wikidata | Q108820186 |
General Information |
|
Publications | |
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: allowed
|
Subclone of |
Donor Information
General Donor Information |
|
Sex | female |
Ethnicity | Han |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Disease associated phenotypes | no phenotypes |
Karyotyping (Donor) |
|
Has the donor karyotype been analysed? |
No
|
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
Yes
Exome sequencing
Health |
External Databases (Donor) |
|
BioSamples | SAMEA8883269 |
Ethics
Also have a look at the ethics information for the parental line
EHTJUi005-A
.
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
EHTJUi005-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Genes | |
Is reprogramming vector detectable? |
No |
Methods used |
RT-PCR
|
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Yes |
Derived under GMP? |
Yes |
Available as clinical grade? |
No |
Culture Conditions
Surface coating | Laminin |
Feeder cells |
No |
Passage method |
Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
|
CO2 Concentration | 5 % |
Medium |
Other medium:
Base medium: stemfit
Main protein source: Serum concentration: % |
Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No |
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
Self-renewal
Positive
Endoderm
Unknown
Mesoderm
Unknown
Ectoderm score
Unknown
alkaline phosphatase staining
Differentiation Potency
In vitro directed differentiation
Microbiology / Virus Screening |
|
HIV 1 | Negative |
HIV 2 | Negative |
Hepatitis B | Negative |
Hepatitis C | Negative |
Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
46,XX
Passage number: 26
Karyotyping method:
G-Banding
|
Other Genotyping (Cell Line) |
|
Is there genome-wide genotyping or functional data available? |
Yes
Exome sequencing
|
Genetic Modification
Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.